A man’s risk of developing advanced stage prostate cancer may depend on how much melatonin he produces while he is asleep, suggest researchers.
Sarah Markt (Harvard School of Public Health, Boston, USA) and colleagues say their study showed a significantly reduced risk for the more aggressive form of prostate cancer in men with higher rather than lower levels of the sleep hormone.
“Because melatonin levels are potentially modifiable, further studies of melatonin and prostate cancer risk and progression are warranted,” stated Markt, who presented the findings at the ACCR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research in San Diego, USA.
Melatonin may influence prostate cancer stage
Editorial Comment:
Pay attention, guys... from further down in the article, especially the first paragraph:
The results also showed that men who reported difficulty getting to sleep, staying asleep or who took medication to aid their sleep, had significantly lower levels of the marker in their urine than men who did not report sleep problems.
“Sleep loss and other factors can influence the amount of melatonin secretion or block it altogether, and health problems associated with melatonin, disrupted sleep, and/or disruption of the circadian rhythm are broad, including a potential risk for cancer,” explained Markt.
I would be interested to see further work on this and see how the research evolves.
Sarah Markt (Harvard School of Public Health, Boston, USA) and colleagues say their study showed a significantly reduced risk for the more aggressive form of prostate cancer in men with higher rather than lower levels of the sleep hormone.
“Because melatonin levels are potentially modifiable, further studies of melatonin and prostate cancer risk and progression are warranted,” stated Markt, who presented the findings at the ACCR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research in San Diego, USA.
Melatonin may influence prostate cancer stage
Editorial Comment:
Pay attention, guys... from further down in the article, especially the first paragraph:
The results also showed that men who reported difficulty getting to sleep, staying asleep or who took medication to aid their sleep, had significantly lower levels of the marker in their urine than men who did not report sleep problems.
“Sleep loss and other factors can influence the amount of melatonin secretion or block it altogether, and health problems associated with melatonin, disrupted sleep, and/or disruption of the circadian rhythm are broad, including a potential risk for cancer,” explained Markt.
I would be interested to see further work on this and see how the research evolves.
Comment